KOR

e-Article

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial
Document Type
Journal
Source
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; DEC 5 2023, 330 21, p2064-p2074, 11p.
Subject
Language
English
ISSN
15383598